Slide background




ISO 14971: Medical devices - Application of risk management to medical devices

ID 1919 | | Visite: 9288 | Documenti normazione ENTIPermalink: https://www.certifico.com/id/1919

ISO 14971:2007(*)
Medical devices - Application of risk management to medical devices

Update 18 dicembre 2019

Pubblicata da ISO il 18 Dicembre 2019 la ISO 14971:2019 Medical devices - Application of risk management to medical devices

Harmonised standard (i.e. it can be used as a presumption of conformity to aspects of the various device directives), is EN ISO 14971:2012

ISO 14971:2007 (EN ISO 14971:2012) specifies a process for a manufacturer to identify the hazards associated with medical devices, including in vitro diagnostic (IVD) medical devices, to estimate and evaluate the associated risks, to control these risks, and to monitor the effectiveness of the controls.

The requirements of ISO 14971:2007 are applicable to all stages of the life-cycle of a medical device.

In July 2013, the International Standardisation Organisation (ISO) published the guidance document ISO/TR 24971:2013 "Medical devices - Guidance on the application of ISO 14971“. The guidance document includes additional information on some very important aspects of the ISO 14971 standard. Considering these aspects in connection with their risk management processes is worthwhile for manufacturers. The key aspects at a glance:

Product standards:

Where international product safety standards propose specific (and measurable) risk controls to address the particular hazards of a product, the residual risk can be evaluated as acceptable when said risk controls have been implemented and successfully verified, unless there is a clear indication that the risk controls are inadequate. 

Differentiation between "information for safety" and "disclosure of residual risk"

The guidance specifies that the ISO 14971 standard differentiates between "information for safety" and "disclosure of residual risk". It clearly points out that "information for safety" is considered to be a risk control measure with a certain effectiveness. The effectiveness of the measure must be verified. This can be carried out by applying the usability engineering process in accordance with IEC 62366. This clarification is very important with respect to the content deviations identified in the European version of the standard EN ISO 14971:2012. 

Acceptability of overall residual risk

After all risks have been mitigated, the manufacturers must evaluate the overall residual risk. The guidance document establishes the criteria for such an evaluation and also specifies that an evaluation of the overall residual risk may not, or may not solely, be based on the fact that all individual risks are acceptable. 

Policy for determining the criteria for risk acceptability

The guidance document explains how to fulfil the requirement of the ISO 14971 standard that top management has to "define and document the policy for determining criteria for risk acceptability". 

Production and post-production feedback loop

The guidance document adds some information to this process step of the ISO 14971 standard.

(*) This standard was last reviewed in 2010 (ISO standards are reviewed every five years).



Tags: Normazione Norme armonizzate direttiva dispositivi medici Abbonati Normazione

Articoli correlati

Ultimi archiviati Normazione

Norme armonizzate REACH
Apr 20, 2021 108

Norme armonizzate REACH Aprile 2021

Norme armonizzate REACH Aprile 2021 Titles and references of standards to be used as the test methods for demonstrating the conformity of articles under entry 27 of Annex XVII to Regulation (EC) n° 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation,… Leggi tutto
Decisione di esecuzione UE 2021 611
Apr 15, 2021 175

Decisione di esecuzione (UE) 2021/611

Decisione di esecuzione (UE) 2021/611 | Norme armonizzate DM impiantabili attivi della Commissione del 14 aprile 2021 che modifica la decisione di esecuzione (UE) 2020/438 per quanto riguarda le norme armonizzate sulla valutazione biologica dei dispositivi medici, sugli imballaggi per dispositivi… Leggi tutto
Decisione 2021 609
Apr 15, 2021 105

Decisione di esecuzione (UE) 2021/609

Decisione di esecuzione (UE) 2021/609 | Norme armonizzate IVDD della Commissione del 14 aprile 2021 che modifica la decisione di esecuzione (UE) 2020/439 per quanto riguarda le norme armonizzate sugli imballaggi per dispositivi medici sterilizzati terminalmente e sulla sterilizzazione dei… Leggi tutto
Apr 09, 2021 138

ISO 17420-1:2021

ISO 17420-1:2021 This document specifies general requirements for the performance and testing of respiratory protective devices (RPD) in accordance with their classification and for use in the workplace to protect the wearer from hazardous atmospheres and/or environments. The requirements are based… Leggi tutto
Apr 02, 2021 179

UNI 10819:2021

UNI 10819:2021 Luce e illuminazione - Impianti di illuminazione esterna - grandezze illuminotecniche e procedure di calcolo per la valutazione della dispersione verso l'alto del flusso luminoso La norma prescrive i metodi di calcolo e verifica per la valutazione del flusso luminoso disperso verso… Leggi tutto

Più letti Normazione